Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.

Biological research for nursing - 1 Jul 2009

Adegbola Maxine A

Abstract excerpt

UNLABELLED: This literature review explores the potential of genomics to explain, or at least contribute to the discussion about, heterogeneity in chronic pain in sickle-cell disease (SCD). BACKGROUND: Adults with SCD, a single-gene disorder, are living longer than in years past, yet report being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analgesics, Opioid
Share to Anemia, Sickle Cell
Share to Catechol O-Methyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucuronosyltransferase

Share to Morphine

Share to Nurse's Role

Share to Receptors, Opioid, mu

Source

Identifiers

PMID: 19487302
DOI: 10.1177/1099800409337154

Genes

SCD
COMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19487302-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.PMID 19487302Read ↗

Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.Semantic proximity Read ↗

An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision MedicineSemantic proximity Read ↗

Association of COMT rs4680 Genotype With Chronic Neuropathic Pain Experience in Patients With Sickle Cell Disease.Semantic proximity Read ↗

S100B single nucleotide polymorphisms exhibit sex-specific associations with chronic pain in sickle cell disease in a largely African-American cohort.Semantic proximity Read ↗

Genetic predictors of acute and chronic pain.Semantic proximity Read ↗

Genetic basis for individual variations in pain perception and the development of a chronic pain conditionSemantic proximity Read ↗

Genetic variants of GCH1 associate with chronic and acute crisis pain in African Americans with sickle cell disease.Semantic proximity Read ↗

Pharmacogenetics of morphine: Potential implications in sickle cell disease.Semantic proximity Read ↗

Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell DiseaseSemantic proximity Read ↗

The Multifaceted Nature of Pain in Sickle Cell Disease: From Molecular Mechanisms to Emerging Therapeutic FrontiersSemantic proximity Read ↗

HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease.Semantic proximity Read ↗

Genetic and epigenetic epidemiology of chronic widespread painSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.